UK markets closed

Avidity Biosciences, Inc. (RNA)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
23.93-1.16 (-4.62%)
As of 12:31PM EDT. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
9,560
9,560
9,224
9,326
6,787
Operating expenses
Research development
190,968
190,968
150,404
101,182
37,602
Selling general and administrative
54,190
54,190
37,733
26,195
13,462
Total operating expenses
245,158
245,158
188,137
127,377
51,064
Operating income or loss
-235,598
-235,598
-178,913
-118,051
-44,277
Interest expense
-
-
0
0
209
Total other income/expenses net
-594
-594
-57
-62
-75
Income before tax
-212,220
-212,220
-173,995
-118,009
-44,355
Income from continuing operations
-212,220
-212,220
-173,995
-118,009
-44,355
Net income
-212,220
-212,220
-173,995
-118,009
-44,355
Net income available to common shareholders
-212,220
-212,220
-173,995
-118,009
-44,355
Basic EPS
-3.00
-
-3.34
-2.85
-2.05
Diluted EPS
-3.00
-
-3.34
-2.85
-2.05
Basic average shares
68,328
-
52,162
41,428
21,663
Diluted average shares
68,328
-
52,162
41,428
21,663